#Thinksabio latest news RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn’s Disease Post navigation #AUNA-SEC-Update-(21-JUL-2025)-ThinkSabio-Stocks Simplified)#LKFN-SEC-Update-(21-JUL-2025)-ThinkSabio-Stocks Simplified)